Vaccines that protect against severe illness, death and lingering long COVID-19 symptoms from a SARS-CoV-2 infection were linked to small increases in neurological, blood and heart-related conditions in the largest global vaccine safety study to date.
The rare events — identified early in the pandemic — included a higher risk of heart-related inflammation from mRNA shots made by Pfizer Inc, BioNTech SE and Moderna Inc, and an increased risk of a type of blood clot in the brain after immunization with viral-vector vaccines such as the one developed by the University of Oxford and made by AstraZeneca PLC.
The viral-vector jabs were also tied to an increased risk of Guillain-Barre syndrome, a neurological disorder in which the immune system mistakenly attacks the peripheral nervous system.
Photo: AP
More than 13.5 billion doses of COVID-19 vaccines have been administered globally over the past three years, saving more than 1 million lives in Europe alone. Still, a small proportion of people immunized were injured by the shots, stoking debate about their benefits versus harms.
The new research, by the Global Vaccine Data Network, was published in the journal Vaccine last week, with the data made available via interactive dashboards to show methodology and specific findings.
The research looked for 13 medical conditions that the group considered “adverse events of special interest” among 99 million vaccinated individuals in eight countries, aiming to identify higher-than-expected cases after a COVID-19 shot. The use of aggregated data increased the possibility of identifying rare safety signals that might have been missed when looking only at smaller populations.
Myocarditis, or inflammation of the heart muscle, was consistently identified following a first, second and third dose of mRNA vaccines, the study found. The highest increase in the observed-to-expected ratio was seen after a second jab with the Moderna shot. A first and fourth dose of the same vaccine was also tied to an increase in pericarditis, or inflammation of the thin sac covering the heart.
Researchers found a statistically significant increase in cases of Guillain-Barre syndrome within 42 days of an initial Oxford-developed ChAdOx1 or “Vaxzevria” shot that was not observed with mRNA vaccines. Based on the background incidence of the condition, 66 cases were expected — but 190 events were observed.
ChAdOx1 was linked to a threefold increase in cerebral venous sinus thrombosis, a type of blood clot in the brain, identified in 69 events, compared with an expected 21. The small risk led to the vaccine’s withdrawal or restriction in Denmark and multiple other countries. Myocarditis was also linked to a third dose of ChAdOx1 in some, but not all, populations studied.
Possible safety signals for transverse myelitis — spinal cord inflammation — after viral-vector vaccines was identified in the study. So was acute disseminated encephalomyelitis — inflammation and swelling in the brain and spinal cord — after both viral-vector and mRNA vaccines.
Seven cases of acute disseminated encephalomyelitis after vaccination with the Pfizer-BioNTech vaccine were observed, versus an expectation of two.
The adverse events of special interest were selected based on pre-established associations with immunization, what was already known about immune-related conditions and pre-clinical research. The study did no monitor for postural orthostatic tachycardia syndrome, or POTS, that some research has linked with COVID-19 vaccines.
Exercise intolerance, excessive fatigue, numbness and “brain fog” were among common symptoms identified in more than 240 adults experiencing chronic post-vaccination syndrome in a separate study conducted by the Yale School of Medicine. The cause of the syndrome is not yet known, and it has no diagnostic tests or proven remedies.
The Yale research aims to understand the condition to relieve the suffering of those affected and improve the safety of vaccines, said Harlan Krumholz, a principal investigator of the study, and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation.
“Both things can be true,” Krumholz said in an interview. “They can save millions of lives, and there can be a small number of people who’ve been adversely affected.”
Auschwitz survivor Eva Schloss, the stepsister of teenage diarist Anne Frank and a tireless educator about the horrors of the Holocaust, has died. She was 96. The Anne Frank Trust UK, of which Schloss was honorary president, said she died on Saturday in London, where she lived. Britain’s King Charles III said he was “privileged and proud” to have known Schloss, who cofounded the charitable trust to help young people challenge prejudice. “The horrors that she endured as a young woman are impossible to comprehend and yet she devoted the rest of her life to overcoming hatred and prejudice, promoting kindness, courage, understanding
US President Donald Trump on Friday said Washington was “locked and loaded” to respond if Iran killed protesters, prompting Tehran to warn that intervention would destabilize the region. Protesters and security forces on Thursday clashed in several Iranian cities, with six people reported killed, the first deaths since the unrest escalated. Shopkeepers in Tehran on Sunday last week went on strike over high prices and economic stagnation, actions that have since spread into a protest movement that has swept into other parts of the country. If Iran “violently kills peaceful protesters, which is their custom, the United States of America will come to
‘DISRESPECTFUL’: Katie Miller, the wife of Trump’s most influential adviser, drew ire by posting an image of Greenland in the colors of the US flag, captioning it ‘SOON’ US President Donald Trump on Sunday doubled down on his claim that Greenland should become part of the US, despite calls by the Danish prime minister to stop “threatening” the territory. Washington’s military intervention in Venezuela has reignited fears for Greenland, which Trump has repeatedly said he wants to annex, given its strategic location in the arctic. While aboard Air Force One en route to Washington, Trump reiterated the goal. “We need Greenland from the standpoint of national security, and Denmark is not going to be able to do it,” he said in response to a reporter’s question. “We’ll worry about Greenland in
PERILOUS JOURNEY: Over just a matter of days last month, about 1,600 Afghans who were at risk of perishing due to the cold weather were rescued in the mountains Habibullah set off from his home in western Afghanistan determined to find work in Iran, only for the 15-year-old to freeze to death while walking across the mountainous frontier. “He was forced to go, to bring food for the family,” his mother, Mah Jan, said at her mud home in Ghunjan village. “We have no food to eat, we have no clothes to wear. The house in which I live has no electricity, no water. I have no proper window, nothing to burn for heating,” she added, clutching a photograph of her son. Habibullah was one of at least 18 migrants who died